Mark R. Crowley

758 total citations
18 papers, 515 citations indexed

About

Mark R. Crowley is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Physiology. According to data from OpenAlex, Mark R. Crowley has authored 18 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Infectious Diseases and 5 papers in Physiology. Recurrent topics in Mark R. Crowley's work include Viral Infections and Vectors (6 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Viral Infections and Outbreaks Research (4 papers). Mark R. Crowley is often cited by papers focused on Viral Infections and Vectors (6 papers), Pulmonary Hypertension Research and Treatments (5 papers) and Viral Infections and Outbreaks Research (4 papers). Mark R. Crowley collaborates with scholars based in United States, Chile and Canada. Mark R. Crowley's co-authors include Robert Katz, H. William Kelly, Brian Hjelle, Jorge A. Wernly, Scott J. Soifer, Gary K. Iwamoto, Vinko Tomicić, Pablo Vial, Grégory Mertz and Betty Chang and has published in prestigious journals such as PEDIATRICS, Journal of Applied Physiology and Critical Care Medicine.

In The Last Decade

Mark R. Crowley

18 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Crowley United States 12 264 147 145 136 70 18 515
Nesrin Turan Türkiye 13 137 0.5× 131 0.9× 28 0.2× 25 0.2× 72 1.0× 44 595
Raúl Riquelme Chile 9 161 0.6× 37 0.3× 76 0.5× 13 0.1× 56 0.8× 20 385
Ricardo Espinoza Chile 11 70 0.3× 56 0.4× 12 0.1× 49 0.4× 25 0.4× 42 440
Benjamin Coiffard France 15 59 0.2× 194 1.3× 8 0.1× 80 0.6× 18 0.3× 69 654
Wenyi Zhang China 9 64 0.2× 29 0.2× 20 0.1× 60 0.4× 21 0.3× 21 288
Alexander Auais United States 12 104 0.4× 293 2.0× 8 0.1× 165 1.2× 12 0.2× 17 640
Ajay Kevat Australia 9 29 0.1× 146 1.0× 6 0.0× 30 0.2× 29 0.4× 25 326
J. Anthony G. Scott United States 10 67 0.3× 32 0.2× 15 0.1× 45 0.3× 85 1.2× 22 680
Junichi Inoue Japan 12 27 0.1× 48 0.3× 15 0.1× 19 0.1× 38 0.5× 46 589
M. Georgi Germany 9 18 0.1× 68 0.5× 13 0.1× 202 1.5× 193 2.8× 55 618

Countries citing papers authored by Mark R. Crowley

Since Specialization
Citations

This map shows the geographic impact of Mark R. Crowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Crowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Crowley more than expected).

Fields of papers citing papers by Mark R. Crowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Crowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Crowley. The network helps show where Mark R. Crowley may publish in the future.

Co-authorship network of co-authors of Mark R. Crowley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Crowley. A scholar is included among the top collaborators of Mark R. Crowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Crowley. Mark R. Crowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wernly, Jorge A., et al.. (2011). Extracorporeal membrane oxygenation support improves survival of patients with Hantavirus cardiopulmonary syndrome refractory to medical treatment☆. European Journal of Cardio-Thoracic Surgery. 40(6). 1334–1340. 42 indexed citations
2.
Dietl, Charles A., et al.. (2008). Extracorporeal membrane oxygenation support improves survival of patients with severe Hantavirus cardiopulmonary syndrome. Journal of Thoracic and Cardiovascular Surgery. 135(3). 579–584. 39 indexed citations
3.
Chang, Betty, Mark R. Crowley, Matthew J. Campen, & Frederick Koster. (2007). Hantavirus Cardiopulmonary Syndrome. Seminars in Respiratory and Critical Care Medicine. 28(2). 193–200. 43 indexed citations
4.
Mertz, Grégory, Brian Hjelle, Mark R. Crowley, et al.. (2006). Diagnosis and treatment of new world hantavirus infections. Current Opinion in Infectious Diseases. 19(5). 437–442. 79 indexed citations
5.
Dominguez, Karen, et al.. (2006). Withdrawal from Lorazepam in Critically III Children. Annals of Pharmacotherapy. 40(6). 1035–1039. 19 indexed citations
6.
Raissy, Hengameh, et al.. (2003). Comparison of the Systemic Effects of Fluticasone Propionate and Triamcinolone Acetonide Administered in Equipotent Doses in Children with Asthma. Pediatric Asthma Allergy & Immunology. 16(4). 283–293. 1 indexed citations
7.
Ramos, Mary M., Gary D. Overturf, Mark R. Crowley, Robert B. Rosenberg, & Brian Hjelle. (2001). Infection With Sin Nombre Hantavirus: Clinical Presentation and Outcome in Children and Adolescents. PEDIATRICS. 108(2). e27–e27. 24 indexed citations
8.
Colón‐Semidey, Angel, Patricia L. Marshik, Mark R. Crowley, Robert Katz, & H. William Kelly. (2000). Correlation between reversibility of airway obstruction and exhaled nitric oxide levels in children with stable bronchial asthma. Pediatric Pulmonology. 30(5). 385–392. 49 indexed citations
9.
Crowley, Mark R., Robert Katz, Randolph M. Kessler, et al.. (1998). Successful treatment of adults with severe Hantavirus pulmonary syndrome with extracorporeal membrane oxygenation. Critical Care Medicine. 26(2). 409–414. 63 indexed citations
10.
Crowley, Mark R.. (1997). Oxygen-Induced Pulmonary Vasodilation is Mediated by Adenosine Triphosphate in Newborn Lambs. Journal of Cardiovascular Pharmacology. 30(1). 102–109. 18 indexed citations
11.
Crowley, Mark R., Jeffrey R. Fineman, & Scott J. Soifer. (1994). HA1004, an Intracellular Calcium Antagonist, Selectively Attenuates Pulmonary Hypertension in Newborn Lambs. Journal of Cardiovascular Pharmacology. 23(5). 806–813. 4 indexed citations
12.
Katz, Robert, H. William Kelly, Mark R. Crowley, et al.. (1993). Safety of Continuous Nebulized Albuterol for Bronchospasm in Infants and Children. PEDIATRICS. 92(5). 666–669. 65 indexed citations
13.
Crowley, Mark R.. (1992). EFFECTS OF PENTOXIFYLLINE ON NEWBORN LAMBS WITH PULMONARY HYPERTENSION. Critical Care Medicine. 20(Supplement). S85–S85. 1 indexed citations
14.
Crowley, Mark R., Jeffrey R. Fineman, & Scott J. Soifer. (1991). Effects of Vasoactive Drugs on Thromboxane A2 Mimetic-Induced Pulmonary Hypertension in Newborn Lambs. Pediatric Research. 29(2). 167–172. 11 indexed citations
15.
Fineman, J. R., Mark R. Crowley, M. A. Heymann, & Scott J. Soifer. (1991). In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. Journal of Applied Physiology. 71(2). 735–741. 28 indexed citations
16.
Crowley, Mark R., et al.. (1990). Selective pulmonary vasodilation with ATP-MgCl2 during pulmonary hypertension in lambs. Journal of Applied Physiology. 69(5). 1836–1842. 11 indexed citations
17.
McKay, Donald W., et al.. (1990). Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.. Journal of Pharmacology and Experimental Therapeutics. 253(3). 905–912. 13 indexed citations
18.
Crowley, Mark R., et al.. (1989). Massive hepatic necrosis in a child after administration of phenobarbital.. PubMed. 84(7). 820–2. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nesrin Turan Breakdown of academic impact, for papers by Raúl Riquelme Breakdown of academic impact, for papers by Ricardo Espinoza Breakdown of academic impact, for papers by Benjamin Coiffard Breakdown of academic impact, for papers by Wenyi Zhang Breakdown of academic impact, for papers by Alexander Auais Breakdown of academic impact, for papers by Ajay Kevat Breakdown of academic impact, for papers by J. Anthony G. Scott Breakdown of academic impact, for papers by Junichi Inoue Breakdown of academic impact, for papers by M. Georgi
Rankless by CCL
2026